{
    "title": "Stelara patent deal puts J&J back on path to $57 bln 2025 revenue forecast",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12160277/Stelara-patent-deal-puts-J-J-path-57-bln-2025-revenue-forecast.html",
    "date": "2023-06-05",
    "keywords": [
        "stelara",
        "jampj",
        "amgen",
        "drug",
        "settlement",
        "year",
        "biosimilar",
        "market",
        "company",
        "analyst",
        "wingrove",
        "month",
        "price",
        "deal",
        "divan",
        "alvotech",
        "teva",
        "spokesperson",
        "june",
        "inc",
        "version",
        "blockbuster",
        "psoriasis",
        "treatment",
        "contributor",
        "street",
        "door",
        "availability",
        "reduction",
        "biotech",
        "entry",
        "patent",
        "litigation",
        "average",
        "september",
        "view",
        "april",
        "currency",
        "business",
        "track",
        "projection",
        "skepticism",
        "way",
        "path",
        "number",
        "didnt",
        "vamil",
        "disease",
        "companys",
        "use",
        "phrase",
        "doubt",
        "exclusivity",
        "potential",
        "credit",
        "trung",
        "growth",
        "huynh",
        "avt04",
        "approval",
        "half",
        "note",
        "food",
        "administration",
        "reykjavik",
        "manufacturing",
        "plant",
        "comment",
        "property",
        "agreement",
        "wont",
        "outlook",
        "progress",
        "guidance",
        "building",
        "investor",
        "conference",
        "confidence",
        "target",
        "reporting",
        "editing",
        "humer",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}